BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 184 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,267 | +68.0% | 48,046 | +9.6% | 0.00% | +100.0% |
| Q2 2023 | $754 | -18.2% | 43,849 | -21.2% | 0.00% | 0.0% |
| Q1 2023 | $922 | +67.3% | 55,612 | -23.1% | 0.00% | 0.0% |
| Q4 2022 | $551 | -99.9% | 72,286 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $719,000 | +9.6% | 72,312 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $656,000 | -10.6% | 72,215 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $734,000 | -75.8% | 72,299 | -60.2% | 0.00% | -66.7% |
| Q4 2021 | $3,030,000 | -60.4% | 181,647 | +11.2% | 0.00% | -62.5% |
| Q3 2021 | $7,656,000 | -57.6% | 163,352 | -44.8% | 0.01% | -57.9% |
| Q2 2021 | $18,049,000 | +4.6% | 296,079 | +5.7% | 0.02% | 0.0% |
| Q1 2021 | $17,263,000 | +20.4% | 280,245 | +38.9% | 0.02% | +18.8% |
| Q4 2020 | $14,342,000 | +382.2% | 201,689 | +154.5% | 0.02% | +300.0% |
| Q3 2020 | $2,974,000 | +15.0% | 79,256 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $2,585,000 | +57.0% | 79,256 | +39.5% | 0.00% | +50.0% |
| Q1 2020 | $1,647,000 | +135.0% | 56,800 | +184.0% | 0.00% | +100.0% |
| Q4 2019 | $701,000 | +84.5% | 20,000 | +13.0% | 0.00% | – |
| Q3 2019 | $380,000 | – | 17,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |